Zhengming Yan

810 total citations
15 papers, 569 citations indexed

About

Zhengming Yan is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Zhengming Yan has authored 15 papers receiving a total of 569 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 8 papers in Molecular Biology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Zhengming Yan's work include Cancer Cells and Metastasis (4 papers), Advanced Breast Cancer Therapies (3 papers) and Microtubule and mitosis dynamics (3 papers). Zhengming Yan is often cited by papers focused on Cancer Cells and Metastasis (4 papers), Advanced Breast Cancer Therapies (3 papers) and Microtubule and mitosis dynamics (3 papers). Zhengming Yan collaborates with scholars based in United States, China and United Kingdom. Zhengming Yan's co-authors include Cory L. Painter, Haoyun An, Jerald S. Bradshaw, Reed M. Izatt, Cathy C. Zhang, James G. Christensen, Maruja E. Lira, Qin Zhang, Maria E. Arango and Anthony Wong and has published in prestigious journals such as Chemical Reviews, Cancer Research and Clinical Cancer Research.

In The Last Decade

Zhengming Yan

15 papers receiving 561 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Zhengming Yan United States	12	294	211	90	82	67	15	569
Cheng Cheng Zhang United States	12	334 1.1×	199 0.9×	35 0.4×	150 1.8×	64 1.0×	14	978
Richard R. de Haas Netherlands	16	543 1.8×	218 1.0×	74 0.8×	174 2.1×	42 0.6×	24	906
Oren Dwir Israel	15	357 1.2×	122 0.6×	122 1.4×	41 0.5×	120 1.8×	17	903
Kevin Litwiler United States	15	717 2.4×	379 1.8×	84 0.9×	68 0.8×	49 0.7×	29	1.1k
Irina Druzhkova Russia	11	235 0.8×	80 0.4×	39 0.4×	101 1.2×	41 0.6×	34	462
Erin Jackson United States	5	464 1.6×	534 2.5×	76 0.8×	95 1.2×	41 0.6×	9	1.1k
Rebekka Hueting United Kingdom	15	175 0.6×	295 1.4×	42 0.5×	87 1.1×	209 3.1×	19	720
Atanu Ghorai India	13	218 0.7×	212 1.0×	27 0.3×	85 1.0×	28 0.4×	18	451
Shaun D. Fontaine United States	14	397 1.4×	194 0.9×	60 0.7×	36 0.4×	155 2.3×	23	750
Maria M. Lukina Russia	19	359 1.2×	101 0.5×	77 0.9×	156 1.9×	105 1.6×	54	878

Countries citing papers authored by Zhengming Yan

Since Specialization

Citations

This map shows the geographic impact of Zhengming Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhengming Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhengming Yan more than expected).

Fields of papers citing papers by Zhengming Yan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhengming Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhengming Yan. The network helps show where Zhengming Yan may publish in the future.

Co-authorship network of co-authors of Zhengming Yan

This figure shows the co-authorship network connecting the top 25 collaborators of Zhengming Yan. A scholar is included among the top collaborators of Zhengming Yan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhengming Yan. Zhengming Yan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Liang, Xiang-Jing, Zhengming Yan, Jingyang Chen, et al.. (2022). A DNA-Methylation-Driven Genes Based Prognostic Signature Reveals Immune Microenvironment in Pancreatic Cancer. Frontiers in Immunology. 13. 21 indexed citations

Liao, Wei, Jiecheng Xu, Zhengming Yan, et al.. (2021). Therapeutic Potential of CUDC-907 (Fimepinostat) for Hepatocarcinoma Treatment Revealed by Tumor Spheroids-Based Drug Screening. Frontiers in Pharmacology. 12. 658197–658197. 16 indexed citations

Zhang, Cathy C., Zhengming Yan, Bernadette Pascual, et al.. (2017). Gemtuzumab Ozogamicin (GO) Inclusion to Induction Chemotherapy Eliminates Leukemic Initiating Cells and Significantly Improves Survival in Mouse Models of Acute Myeloid Leukemia. Neoplasia. 20(1). 1–11. 16 indexed citations

Zhang, Cathy C., Zhengming Yan, Anand Giddabasappa, et al.. (2014). Comparison of dynamic contrast‐enhanced MR, ultrasound and optical imaging modalities to evaluate the antiangiogenic effect of PF‐03084014 and sunitinib. Cancer Medicine. 3(3). 462–471. 17 indexed citations

O’Brien, Peter J., Michelle Lee, Mary E. Spilker, et al.. (2013). Monitoring metabolic responses to chemotherapy in single cells and tumors using nanostructure-initiator mass spectrometry (NIMS) imaging. Cancer & Metabolism. 1(1). 4–4. 41 indexed citations

Zhang, Cathy C., Zhengming Yan, Douglas D. Fang, et al.. (2013). Synergistic Effect of the γ-Secretase Inhibitor PF-03084014 and Docetaxel in Breast Cancer Models. Stem Cells Translational Medicine. 2(3). 233–242. 78 indexed citations

Zhang, Cathy C., Adam Pavlı́c̀ek, Qin Zhang, et al.. (2012). Biomarker and Pharmacologic Evaluation of the γ-Secretase Inhibitor PF-03084014 in Breast Cancer Models. Clinical Cancer Research. 18(18). 5008–5019. 53 indexed citations

Zhang, Cathy C., Zhengming Yan, Douglas D. Fang, et al.. (2012). Abstract 3492: γ-secretase inhibitor PF-03084014 diminishes the tumor-initiating cells and demonstrates synergy with docetaxel in breast cancer xenograft models. Cancer Research. 72(8_Supplement). 3492–3492. 1 indexed citations

Zhang, Cathy C., Zhengming Yan, Wenlin Li, et al.. (2011). [18F]FLT–PET Imaging Does Not Always “Light Up” Proliferating Tumor Cells. Clinical Cancer Research. 18(5). 1303–1312. 62 indexed citations

10.

Zhang, Cathy C., Zhengming Yan, Qin Zhang, et al.. (2010). PF-03732010: A Fully Human Monoclonal Antibody against P-Cadherin with Antitumor and Antimetastatic Activity. Clinical Cancer Research. 16(21). 5177–5188. 58 indexed citations

11.

Zhang, Cathy, Zhengming Yan, Cory L. Painter, et al.. (2009). PF-00477736 Mediates Checkpoint Kinase 1 Signaling Pathway and Potentiates Docetaxel-Induced Efficacy in Xenografts. Clinical Cancer Research. 15(14). 4630–4640. 45 indexed citations

12.

Zhang, Cathy, Zhengming Yan, Maria E. Arango, Cory L. Painter, & Kenna Anderes. (2008). Advancing Bioluminescence Imaging Technology for the Evaluation of Anticancer Agents in the MDA-MB-435-HAL-Luc Mammary Fat Pad and Subrenal Capsule Tumor Models. Clinical Cancer Research. 15(1). 238–246. 32 indexed citations

13.

Zhang, Cathy, Karen Lundgren, Zhengming Yan, et al.. (2008). Pharmacologic properties of AG-012986, a pan-cyclin-dependent kinase inhibitor with antitumor efficacy. Molecular Cancer Therapeutics. 7(4). 818–828. 8 indexed citations

14.

Zhang, Cathy C., Susan E. Kephart, Indrawan McAlpine, et al.. (2005). AG-024322 is a potent and selective multi-targeted CDK inhibitor with broad spectrum anti-proliferative activity. Cancer Research. 65. 1045–1045. 8 indexed citations

15.

An, Haoyun, Jerald S. Bradshaw, Reed M. Izatt, & Zhengming Yan. (1994). Bis- and Oligo(benzocrown ether)s. Chemical Reviews. 94(4). 939–991. 113 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact